Healthcare Supply Chain Academy (HSCA) program launched by International Institute for the Management of Logistics (IML) in collaboration with Ferring Pharmaceuticals, Merck and Supply Chain Operations SA

Healthcare Supply Chain Academy (HSCA) program launched by International Institute for the Management of Logistics (IML) in collaboration with Ferring Pharmaceuticals, Merck and Supply Chain Operations SA

Lausanne, Switzerland – 24 February 2016 –

In collaboration with Ferring Pharmaceuticals, Merck and Supply Chain Operations SA, the International Institute for the Management of Logistics (IML) in Lausanne, part of the Ecole Polytechnique Fédérale de Lausanne (EPFL), today announced the launch of the Healthcare Supply Chain Academy (HSCA) program.

This eleven-­week supply chain management program will provide a unique opportunity for life science professionals to sharpen their supply chain knowledge and create immediate value to their employers. The program is initially cofinanced by Ferring Pharmaceuticals, Merck and
IML. It is designed for highly experienced supply chain practitioners, however the blended training sessions will also benefit industry specific experts in other fields, such as Marketing, Regulatory, Quality/Compliance and/or Finance, looking to develop their understanding of supply chain management.

Participants who successfully complete the program will receive an official Certificate of Advanced Studies (CAS) Diploma from the EPFL.

The intensive program is composed of three different modules:

Module 0: Six weeks of innovative remote supply chain learning (e-­training, collaborative simulation tool and readings) based on academic and practical work.

Modules 1, 2 & 3: One week of intensive on-­site classes and case studies at IML/EPFL in Lausanne.

Module 4: Four weeks work on a supply chain business project defined by the student’s company.

The HSCA will be organized in small classes to maximize student interactions with teachers and allow tailored coaching by Faculty members, creating opportunities for “supply chainers” to enhance their knowledge, managerial capabilities and network with more than 900 IML graduates from over 76 countries.

The idea was initiated from the industry four months ago and a team composed of two main local biopharma players (Ferring Pharmaceuticals and Merck), supply chain professionals and academics worked together and under the umbrella of the IML. The HSCA concept was born.

Professor Philippe Wieser, Director at IML, said: “IML brings 25 years of supply chain research, education and expertise to the booming healthcare sector around lake Geneva. The HSCA has been initiated and supported by global industry leaders Ferring Pharmaceuticals, Merck and Supply Chain Operations SA. I am delighted by such collaboration between
academics and business private sector professionals and excited to run the first sessions of such a smart and full-­bodied academy in June and in October 2016.”

For more information about the program, visit: http:hsca.epfl.ch

Ends

About Institute for the Management of Logistics

IML (International Institute for the Management of Logistics) was created in 1990 by 2 universities, EPFL (Ecole Polytechnique Fédérale de Lausanne) and ENPC (Ecole des Ponts ParisTech), in collaboration with a French professional association AFT-­IFTIM and the support, today, of more than 40 companies and 25 academic members or international organisations.
In 1993 we have organized the first Executive Course in Lausanne. In 1994 the first course in Paris, and since 1995 we organize 2 sessions per year, one in Lausanne in English and one in Paris in French-­English.

In 1998, IML received the Award of Excellence from the Institute of Transport Management (ITM) in Birmingham. As of 2009, we develop a new program called “Executive Master in Global Supply Chain Management”.

In 2015 we count more than 900 graduates represented more than 76 different countries on 5 continents.

http://iml.epfl.ch/

About Ferring Pharmaceuticals

Headquartered in Switzerland, Ferring Pharmaceuticals is a research-­driven, specialty biopharmaceutical group active in global markets. The company identifies, develops and markets innovative products in the areas of reproductive health, urology, gastroenterology, endocrinology
and orthopaedics. Ferring has its own operating subsidiaries in nearly 60 countries and markets its products in 110 countries.

To learn more about Ferring or its products please visit www.ferring.com

About Merck

Merck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-­edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2014, Merck generated sales of € 11.3 billion in 66 countries. Founded in 1668, Merck is the world’s oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck, Darmstadt, Germany holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.

www.merckgroup.com

About Supply Chain Operations SA

Based in Switzerland, Supply Chain Operations SA is a consultancy firm specialized in supporting healthcare companies in the development of their end-­to-­end supply chain management capabilities at strategic, tactical and operational level.

www.supplychainoperations.ch

For more information, please contact